AI MARKET SCANNING

Editas Medicine Inc

AVG HISTORICAL GAP +2.71%
MAX GAP RECORD +15.58%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $EDIT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+2.55%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+0.67%
Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN)
-1.00%
Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN)
+9.51%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
+6.99%
May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE)
+0.65%
Mar 05, 2025 Earnings Release 2025-03-05 (AFTER CLOSE)
-5.85%
Nov 04, 2024 Earnings Release 2024-11-04 (BEFORE OPEN)
-0.34%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.9%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $EDIT

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗